Professor, Michigan State University
Managing Director, D.E. Shaw and Co., L.P.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Amid complaints that the FDA is frustrating innovation in its processing of applications for new medical devices, Biocom has organized a discussion on an alternative. Many companies are now looking at markets outside of the U.S. for their initial launch. More information and online registration is here.